ECA Integrated Solution Berhad (KLSE:ECA)
Malaysia · Delayed Price · Currency is MYR 0.1600
-0.0050 (-3.03%)
At close: Jul 30, 2025
CTI BioPharma Income Statement
Financials in millions MYR. Fiscal year is November - October.
Millions MYR. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2020 |
| 15.2 | 18.8 | 35.6 | 27.53 | 20.51 | 15.37 | Upgrade | |
Revenue Growth (YoY) | -43.77% | -47.18% | 29.32% | 34.22% | 33.47% | 100.33% | Upgrade |
Cost of Revenue | 20.28 | 17 | 17.06 | 15.8 | 9.23 | 6.94 | Upgrade |
Gross Profit | -5.08 | 1.81 | 18.54 | 11.73 | 11.28 | 8.43 | Upgrade |
Selling, General & Admin | 9.28 | 9.2 | 8.17 | 5.43 | 3.18 | 2.73 | Upgrade |
Other Operating Expenses | 0.03 | - | - | - | - | -0 | Upgrade |
Operating Expenses | 9.31 | 9.2 | 8.17 | 5.43 | 3.18 | 2.83 | Upgrade |
Operating Income | -14.39 | -7.4 | 10.37 | 6.3 | 8.1 | 5.59 | Upgrade |
Interest Expense | -0.63 | -0.54 | -0.4 | -0.2 | -0.2 | -0.03 | Upgrade |
Interest & Investment Income | 0.62 | 0.59 | 0.39 | 0.01 | 0 | 0.01 | Upgrade |
Currency Exchange Gain (Loss) | 0 | 0 | 0.52 | 1.79 | 0.01 | -0.03 | Upgrade |
EBT Excluding Unusual Items | -14.4 | -7.35 | 10.88 | 7.9 | 7.92 | 5.54 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.08 | - | Upgrade |
Other Unusual Items | - | - | - | - | 0.01 | 0.03 | Upgrade |
Pretax Income | -14.4 | -7.35 | 10.88 | 7.9 | 8.01 | 5.57 | Upgrade |
Income Tax Expense | 0.48 | 0.48 | 0.1 | 0.1 | -0.17 | - | Upgrade |
Net Income | -14.88 | -7.83 | 10.79 | 7.81 | 8.18 | 5.57 | Upgrade |
Net Income to Common | -14.88 | -7.83 | 10.79 | 7.81 | 8.18 | 5.57 | Upgrade |
Net Income Growth | - | - | 38.18% | -4.53% | 46.89% | 306.50% | Upgrade |
Shares Outstanding (Basic) | 579 | 579 | 578 | 428 | 1 | 1 | Upgrade |
Shares Outstanding (Diluted) | 579 | 579 | 578 | 428 | 1 | 1 | Upgrade |
Shares Change (YoY) | 0.13% | 0.26% | 35.10% | 42649.64% | 0.00% | 400.00% | Upgrade |
EPS (Basic) | -0.03 | -0.01 | 0.02 | 0.02 | 8.18 | 5.57 | Upgrade |
EPS (Diluted) | -0.03 | -0.01 | 0.02 | 0.02 | 8.18 | 5.57 | Upgrade |
EPS Growth | - | - | 2.28% | -99.78% | 46.88% | -18.70% | Upgrade |
Free Cash Flow | -9.17 | -6.09 | 0.8 | 0.68 | 0.59 | -0.93 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.01 | 0.00 | 0.00 | 0.59 | -0.93 | Upgrade |
Gross Margin | -33.39% | 9.61% | 52.09% | 42.61% | 55.00% | 54.83% | Upgrade |
Operating Margin | -94.62% | -39.34% | 29.13% | 22.87% | 39.49% | 36.39% | Upgrade |
Profit Margin | -97.85% | -41.61% | 30.30% | 28.36% | 39.86% | 36.22% | Upgrade |
Free Cash Flow Margin | -60.28% | -32.38% | 2.26% | 2.46% | 2.86% | -6.04% | Upgrade |
EBITDA | -13.14 | -6.25 | 11.02 | 6.45 | 8.27 | 5.76 | Upgrade |
EBITDA Margin | -86.39% | -33.23% | 30.94% | 23.44% | 40.30% | 37.48% | Upgrade |
D&A For EBITDA | 1.25 | 1.15 | 0.64 | 0.16 | 0.17 | 0.17 | Upgrade |
EBIT | -14.39 | -7.4 | 10.37 | 6.3 | 8.1 | 5.59 | Upgrade |
EBIT Margin | -94.62% | -39.34% | 29.13% | 22.87% | 39.49% | 36.39% | Upgrade |
Effective Tax Rate | - | - | 0.89% | 1.21% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.